ASCO 2022 | Current standards in BCG-unresponsive carcinoma in-situ and papillary NMIBC

Karim Chamie, MD, University of California Los Angeles, Los Angeles, CA, talks on BCG-unresponsive high-grade nonmuscle-invasive bladder cancer (NMIBC), highlighting current treatment approaches and areas of unmet need. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.